Market Leadership StudyKIK is the global leader in patient recruitment and retention technology, which positions it as a trusted partner for clinical research organizations, sponsors, and sites seeking innovative solutions to improve trial efficiency and patient engagement.

Acquisition Growth Having been acquired by Syneos Health in September 2021, StudyKIK benefits from integrated healthcare and pharmaceutical resources, making it a strategic option for organizations looking to leverage a comprehensive suite of clinical trial services.

Technological Innovation StudyKIK's award-winning oncology study app and integrated telemedicine services demonstrate a strong commitment to cutting-edge solutions, offering opportunities to expand into specialized trial segments and enhance patient experience.

Financial Opportunity With revenues ranging from 25 to 50 million dollars and a broad client base, presenting tailored solutions that build on StudyKIK’s current digital platforms could significantly boost engagement metrics and contract value.

Expansion Potential The company’s ongoing deployment of app technologies and pre-screening services highlights potential for sales of complementary tech integrations, training, and support services to further enhance patient recruitment and retention outcomes.